Socioeconomic status and cardiovascular risk SCORE
Ewa Podolecka(Medical University of Silesia), Krystyna Kozakiewicz(Medical University of Silesia), Paweł Nadrowski(Medical University of Silesia), Michał Skrzypek(Medical University of Silesia), Agnieszka Doryńska(Institute of Cardiology), Magdalena Kwaśniewska(Medical University of Lodz), Wojciech Drygas(Medical University of Lodz), Andrzej Pająk(Jagiellonian University)
Cited by 9
Related Papers
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|The Lancet|2014|713
PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
|The Lancet Diabetes & Endocrinology|2016|391
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium
|The Lancet|2019|304
Education and wealth inequalities in healthy ageing in eight harmonised cohorts in the ATHLOS consortium: a population-based study
|The Lancet Public Health|2020|160